ad image

Cohort 3 Initial Dosing

1 / 1
TransCode Therapeutics
Announcement

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

TransCode Therapeutics

PR-02-25-NI-03Feb 07, 2025
1 / 1